A detailed history of Janney Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Janney Capital Management LLC holds 114,275 shares of ABBV stock, worth $19.6 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
114,275
Previous 119,062 4.02%
Holding current value
$19.6 Million
Previous $18.5 Million 12.79%
% of portfolio
1.38%
Previous 1.24%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $765,058 - $871,712
-4,787 Reduced 4.02%
114,275 $20.8 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $3.43 Million - $3.87 Million
-24,946 Reduced 17.32%
119,062 $18.5 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $183,953 - $212,953
1,377 Added 0.97%
144,008 $21.5 Million
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $389,844 - $485,135
2,942 Added 2.11%
142,631 $19.2 Million
Q1 2023

Apr 28, 2023

BUY
$144.61 - $166.54 $398,255 - $458,651
2,754 Added 2.01%
139,689 $22.3 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $692,379 - $830,345
5,006 Added 3.79%
136,935 $22.1 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $240,101 - $275,380
1,789 Added 1.37%
131,929 $17.7 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $45,001 - $57,211
327 Added 0.25%
130,140 $19.9 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $146,893 - $182,253
1,113 Added 0.86%
129,813 $21 Million
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $145,889 - $184,592
-1,358 Reduced 1.04%
128,700 $17.4 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $2.3 Million - $2.61 Million
21,581 Added 19.89%
130,058 $14 Million
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $65,861 - $73,373
-626 Reduced 0.57%
108,477 $12.2 Million
Q1 2021

Apr 27, 2021

SELL
$102.3 - $112.62 $211,249 - $232,560
-2,065 Reduced 1.86%
109,103 $11.8 Million
Q4 2020

Jan 25, 2021

SELL
$80.49 - $108.67 $435,772 - $588,339
-5,414 Reduced 4.64%
111,168 $11.9 Million
Q3 2020

Nov 06, 2020

BUY
$85.91 - $100.83 $34,020 - $39,928
396 Added 0.34%
116,582 $10.2 Million
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $8.01 Million - $10.7 Million
109,135 Added 1547.79%
116,186 $11.4 Million
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $5,353 - $8,116
-83 Reduced 1.16%
7,051 $537,000
Q3 2019

Oct 28, 2019

SELL
$62.98 - $75.72 $22,609 - $27,183
-359 Reduced 4.79%
7,134 $540,000
Q1 2019

Apr 30, 2019

SELL
$77.14 - $90.79 $60,863 - $71,633
-789 Reduced 9.53%
7,493 $604,000
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $856 - $1,056
-11 Reduced 0.13%
8,282 $764,000
Q3 2018

Jan 04, 2019

SELL
$88.91 - $98.84 $44.2 Million - $49.1 Million
-496,707 Reduced 98.36%
8,293 $784,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $44.2 Million - $49.2 Million
497,379 Added 6526.43%
505,000 $0
Q2 2018

Jul 24, 2018

BUY
$89.78 - $106.23 $20,828 - $24,645
232 Added 3.14%
7,621 $706,000
Q1 2018

Apr 19, 2018

BUY
$92.01 - $123.21 $19,046 - $25,504
207 Added 2.88%
7,389 $699,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $51,228 - $56,176
-572 Reduced 7.38%
7,182 $694,000
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $541,616 - $691,811
7,754
7,754 $689,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Janney Capital Management LLC Portfolio

Follow Janney Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Capital Management LLC with notifications on news.